News and Announcements
Vonex wins No.1 spot in the CRN Fast 50 Australia
- Published December 03, 2014 11:05AM UTC
- Publisher Wholesale Investor
- Categories Company Updates
CRN has just announced the 50 fastest-growing companies at our annual CRN Fast50 ceremony in Sydney.
I was delighted to celebrate our first-ever No.1 from Western Australia. With year-on-year growth hitting a startling 232.24 percent in the 2014 financial year to reach revenues of $3.7 million, Vonex was a worthy first-placer.
Read more: http://www.crn.com.au/News/398292,crn-reveals-the-2014-fast50.aspx#ixzz3Kms9rIgj
1. Vonex
Growth: 232.24%
2013-14 revenue: $3,741,000
State: WA
Founded: 2009
Employees: 15
Key executive: Brydie McKee
Main activities: Carrier and telco solutions
In their own words: “Our culture is very much around innovation and scalable products and technology. We give the guys all the room to explore and expand. We’ve got a collaborative culture.”
Company Updates
Capital Is Flowing – Just Not to Everyone: Inside Australia’s $1.8 Billion Q1 2026
Australia’s startup ecosystem opened 2026 with a number that demanded attention. In the first three months of the year, $1.8 billion was raised across 81 venture deals and 26 accelerator rounds. That makes Q1 2026 the strongest start to a year since the 2022 boom, up 63% on Q1 2025, and more than double the […]
The control layer for the electrified home
THE MARKET SHIFT Australian households have been pulled into a real-time energy market they never knowingly signed up for. Flat electricity tariffs are disappearing. In their place: dynamic, time-of-use pricing that changes depending on when power is consumed. Electricity is now cheapest when solar floods the grid in the middle of the day — and […]
500 Million Episodes, Limited Treatment: How Patrys is Bridging the Gap in an Underserved Market
In the clinical vocabulary of the Intensive Care Unit, there is perhaps no word that carries as much quiet dread as delirium. It is a “chemical storm” of the brain—an acute dysfunction where the delicate balance between calming and activating signals is scrambled. For the patient, it can be a waking nightmare of hallucinations and […]
Backed By Leading Investment Groups and Family Offices
